4.7 Review

Sex differences in the epidemiology, clinical features, and CrossMark pathophysiology of migraine

Journal

LANCET NEUROLOGY
Volume 16, Issue 1, Pages 76-87

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(16)30293-9

Keywords

-

Funding

  1. Menarini
  2. Bayer Healthcare
  3. Consilient Health

Ask authors/readers for more resources

Migraine is two to three times more prevalent in women than men, and women report a longer attack duration, increased risk of headache recurrence, greater disability, and a longer period of time required to recover. Conditions recognised to be comorbid with migraine indude asthma, anxiety, depression, and other chronic pain conditions, and these comorbidities add to the amount of disability in both sexes. Migraine specifically migraine with aura has been identified as a risk factor for vascular disorders, particularly in women, but because of the scarcity of data, the comparative risk in men has yet to be established. There is evidence implicating the role of female sex hormones as a major factor in determining migraine risk and characteristics, which accounts for sex differences, but there is also evidence to support underlying genetic variance. Although migraine is often recognised in women, it is underdiagnosed in men, resulting in suboptimal management and less participation of men in clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available